2-deoxy-d-glucose Coupons & Savings Card – Discount Prices from $73.22

2-Deoxy-D-glucose (2-DG) is generally considered safe when used appropriately; however, certain risks should be noted. High doses of 2-DG have been associated with a decrease in blood pressure and respiratory rate. In animal studies, intravenous administration of 2-DG at doses of 250 mg/kg and above led to a time-dependent reduction in mean arterial blood pressure, while oral doses of 500 mg/kg and higher resulted in a significant decrease in respiratory frequency.

Long-term use of 2-DG at elevated doses has been linked to cardiac toxicity in animal models. Rats consuming 2-DG in their diet at doses ranging from 0.02 to 0.3 g/kg experienced cardiac vacuolization, and doses above 0.2 g/kg increased mortality rates.

Additionally, 2-DG can interfere with protein glycosylation, leading to endoplasmic reticulum stress. This disruption may result in the accumulation of misfolded proteins, potentially causing cellular dysfunction.

Given these potential risks, it is crucial to use 2-DG under medical supervision, adhering to recommended dosages and monitoring for any adverse effects.

2-Deoxy-D-glucose (2-DG) is a glucose analog that has been explored for its potential in treating various conditions, including cancer and viral infections. While generally well-tolerated, some individuals may experience side effects, which are typically mild and transient. Common Side Effects:

• Fatigue, Sweating, and Light-headedness: These symptoms resemble those of low blood sugar and usually occur shortly after administration, resolving within about an hour.
• Nausea: A small percentage of users may experience nausea, which is generally mild and temporary.
• Elevated Blood Sugar Levels (Hyperglycemia): In some cases, 2-DG can cause a slight increase in blood sugar levels. Rare Side Effects:
• Cardiovascular Effects: High doses of 2-DG have been associated with reversible changes in heart rhythm, such as QTc prolongation.
• Gastrointestinal Discomfort: Individuals with existing gastrointestinal ulcers or erosions may experience stomach pain or aggravation of their condition. Precautions:
• Existing Gastrointestinal Conditions: Those with active, untreated esophageal, gastric, or duodenal ulcers should avoid 2-DG, as it can increase gastric acid production.
• Cardiovascular Concerns: Individuals on medications that extend the QTc interval, with a history of arrhythmias, or with uncontrolled high potassium levels should use 2-DG only under physician supervision.
• Kidney Function: Patients with severe chronic kidney disease should exercise caution due to the drug's excretion route.
• Blood Sugar Management: Diabetic patients should ensure their blood sugar levels are well-controlled to maximize the efficacy of 2-DG. Adhering to recommended dosages and guidelines can help minimize the risk of side effects. It's essential to consult with a healthcare professional before starting 2-DG to ensure it's appropriate for your individual health circumstances.

2-Deoxy-D-glucose (2-DG) is a glucose analog that interferes with normal glucose metabolism, leading to various effects on cellular processes. When combined with certain medications, 2-DG can enhance therapeutic outcomes, particularly in cancer treatment.

In cancer therapy, 2-DG has been shown to increase the effectiveness of standard chemotherapeutic agents. For instance, studies have demonstrated that 2-DG enhances the efficacy of drugs like Adriamycin and Paclitaxel in treating human osteosarcoma and non-small cell lung cancers. This enhancement is thought to occur because 2-DG reduces ATP levels within cancer cells, impairing the function of ATP-dependent drug efflux pumps. As a result, chemotherapeutic agents accumulate more within the cancer cells, leading to increased cell death.

Additionally, combining 2-DG with other metabolic inhibitors has shown promising results. For example, the combination of 2-DG and Metformin, a common anti-diabetic drug, has been found to synergistically inhibit the growth of certain cancer cells. This combination disrupts both glycolysis and mitochondrial oxidative phosphorylation, leading to reduced ATP production and increased oxidative stress, which can induce cancer cell death.

However, it's important to note that 2-DG can have varying effects on seizure activity. In some experimental models, 2-DG has demonstrated anticonvulsant properties, while in others, it has shown proconvulsant effects. These differing outcomes may be due to the complex ways 2-DG interacts with neuronal metabolism and excitability.

Given these interactions, it's crucial for patients to consult with their healthcare providers before starting or combining 2-DG with other treatments. Healthcare professionals can provide personalized advice, considering the potential benefits and risks based on individual health conditions and treatment plans.